Cautious income focused global ETF mix with one high risk leveraged satellite position

Report created on Mar 18, 2026

Risk profile Info

3/7
Cautious
Less risk More risk

Diversification profile Info

4/5
Broadly Diversified
Less diversification More diversification

Positions

The portfolio is built almost entirely from broad ETFs, with four core positions and one small leveraged “satellite.” Around two-thirds sits in global equity trackers, a third in a UK dividend ETF, and a meaningful slice in gold, while the 3x Moderna note is tiny by weight but very punchy. Structurally, this is mostly a plain-vanilla, diversified ETF blend with a single speculative kicker on top. That overall shape fits a cautious-to-moderate risk style, provided the leveraged note’s role is clearly intentional. A useful next step is simply being very clear about which part is long-term core wealth and which part is high-risk “fun money.”

Growth Info

Historically, the portfolio shows a strong compound annual growth rate (CAGR) of 15.71%, with a relatively modest max drawdown of -12.67%. CAGR is the “average speed” of growth per year, smoothing out ups and downs over time. A drawdown measures the worst peak‑to‑trough loss. Compared with typical broad equity benchmarks like the S&P 500 or global indices, that mix of high growth and shallow drawdown is unusually attractive for a cautious risk score. Still, this data reflects a specific past period and may be flattered by tech, quality, and low interest rates. It’s helpful confirmation that the structure has worked so far, but not a guarantee.

Projection Info

The Monte Carlo results look odd on the surface, with most simulated paths showing very large losses and only 44 of 1,000 runs ending positive. Monte Carlo simulation takes historical return patterns and mixes them many times to create a range of possible futures; it’s like running thousands of “what if” market paths. Here, the strongly negative median and average results almost certainly reflect the leveraged Moderna note’s extreme volatility combined with a limited history window. That highlights two things: simulations are only as good as the inputs, and leveraged products can dominate forecasted risk. Treat these projections as a warning light around the leveraged piece, not a verdict on the whole portfolio.

Asset classes Info

  • Stocks
    87%
  • Other
    17%

Asset‑class wise, about 87% is in equities and around 17% in “other,” which here is mainly gold. That’s a fairly growth‑oriented stance for a cautious risk profile, but the gold slice provides a useful diversifier that often behaves differently from stocks, especially during crises or inflation scares. Compared with common cautious blended portfolios that might mix in bonds, this structure is more “equity plus hedge” than “equity plus fixed income.” For a long time horizon, that can be fine, but shorter‑term goals might prefer more explicit bond exposure to smooth the ride. The upside is simple: global stocks for growth, gold as a shock absorber.

Sectors Info

  • Financials
    19%
  • Technology
    14%
  • Health Care
    8%
  • Consumer Staples
    7%
  • Consumer Discretionary
    7%
  • Telecommunications
    7%
  • Utilities
    5%
  • Industrials
    5%
  • Energy
    5%
  • Basic Materials
    4%
  • Real Estate
    3%

Sector exposure is broad: financials are the largest at 19%, with technology at 14%, healthcare at 8%, then a good spread across defensives, cyclicals, communications, utilities, industrials, energy, materials, and real estate. That’s a healthy, multi‑sector mix, and the sector balance is broadly similar to global benchmarks, which is a strong indicator of diversification. The tech weight is meaningful but not extreme, tempering volatility compared with tech‑heavy portfolios that can swing sharply during rate changes. The notable angle is the extra tilt toward financials and traditional UK income names, which may hold up better in value‑friendly environments but lag if growth and high‑multiple tech lead again.

Regions Info

  • North America
    39%
  • Europe Developed
    38%
  • Japan
    2%
  • Asia Emerging
    2%
  • Asia Developed
    2%
  • Africa/Middle East
    1%
  • Australasia
    1%

Geographically, the portfolio is nicely split between North America (39%) and developed Europe (38%), with small allocations across Japan, developed Asia, emerging Asia, Africa/Middle East, and Australasia. That’s far more global than a typical UK‑only investor and aligns well with broad global equity norms, which is a big positive for diversification. The one clear tilt is a heavier home bias to UK/Europe relative to some world indices that lean more toward the US. Home bias can feel more comfortable and support dividend goals but can also mean missing some of the US market’s dominance if that continues. Overall, the geographic mix is well-balanced and globally aware.

Market capitalization Info

  • Mega-cap
    34%
  • Mid-cap
    26%
  • Large-cap
    26%
  • No data
    16%
  • Small-cap
    1%

By market cap, there’s a strong lean to large and mega‑cap stocks: about 34% mega, 26% big, 26% medium, with only 1% in small caps and almost nothing in micro caps. Large caps are typically more stable, established businesses, so this tilt usually means less volatility and more resilience in downturns than a small‑cap‑heavy portfolio. That aligns well with a cautious profile that still wants equity growth. The trade‑off is potentially lower long‑term return versus a blend with more small caps, which historically have sometimes delivered higher returns in exchange for bumpier rides. For someone prioritizing stability and income, this large‑cap bias is a sensible foundation.

True holdings Info

  • Moderna Inc
    6.15%
    Part of fund(s):
    • Leverage Shares 3x Long Moderna (MRNA) ETP Securities
  • NVIDIA Corporation
    2.77%
    Part of fund(s):
    • Vanguard FTSE All-World UCITS ETF USD Accumulation
    • iShares VII PLC - iShares Core S&P 500 UCITS ETF
  • Apple Inc
    2.34%
    Part of fund(s):
    • Vanguard FTSE All-World UCITS ETF USD Accumulation
    • iShares VII PLC - iShares Core S&P 500 UCITS ETF
  • Microsoft Corporation
    1.92%
    Part of fund(s):
    • Vanguard FTSE All-World UCITS ETF USD Accumulation
    • iShares VII PLC - iShares Core S&P 500 UCITS ETF
  • Rio Tinto PLC
    1.75%
    Part of fund(s):
    • iShares UK Dividend UCITS
  • BP PLC
    1.47%
    Part of fund(s):
    • iShares UK Dividend UCITS
  • HSBC Holdings PLC
    1.45%
    Part of fund(s):
    • iShares UK Dividend UCITS
  • Legal & General Group PLC
    1.43%
    Part of fund(s):
    • iShares UK Dividend UCITS
  • British American Tobacco PLC
    1.37%
    Part of fund(s):
    • iShares UK Dividend UCITS
  • Amazon.com Inc
    1.36%
    Part of fund(s):
    • Vanguard FTSE All-World UCITS ETF USD Accumulation
    • iShares VII PLC - iShares Core S&P 500 UCITS ETF
  • Top 10 total 22.01%

Looking through the ETFs, Moderna shows up heavily: 6.15% total exposure even though the 3x product is only about 2% by weight. NVIDIA, Apple, Microsoft, Amazon, and big UK names like Rio Tinto, BP, HSBC, and BAT also appear via multiple funds. Overlap means several funds are partly “betting” on the same companies, which can quietly increase concentration. Because only ETF top‑10s are counted, the true overlap is likely a bit higher. The key takeaway is that health‑tech and mega‑cap growth stocks are more influential than weights alone suggest, which can boost returns in good times but make the portfolio more sensitive to news around a handful of big names.

Factors Info

Value
Preference for undervalued stocks
Very high
Data availability: 16%
Size
Exposure to smaller companies
Very low
Data availability: 33%
Momentum
Exposure to recently outperforming stocks
High
Data availability: 100%
Quality
Preference for financially healthy companies
No data
Data availability: 0%
Yield
Preference for dividend-paying stocks
Very high
Data availability: 33%
Low Volatility
Preference for stable, lower-risk stocks
Neutral
Data availability: 33%

Factor exposure shows strong tilts to value (85%), yield (85%), and momentum (73.8%), with moderate low‑volatility exposure and positive size tilt. Factors are underlying characteristics like “cheapness” (value), “recent strong performance” (momentum), and “high dividends” (yield) that research links to returns. A portfolio tilted to value and yield tends to favor cheaper, income‑producing stocks, which can shine when markets rotate away from expensive growth. The strong momentum tilt means holdings that have done well recently, which helps in trending markets but can hurt in sharp reversals. Limited data coverage means these numbers are approximate, but the broad story is clear: this is an income‑oriented, value‑leaning portfolio with a noticeable momentum flavour.

Risk contribution Info

  • Vanguard FTSE All-World UCITS ETF USD Accumulation
    Weight: 32.68%
    30.0%
  • iShares UK Dividend UCITS
    Weight: 32.81%
    28.8%
  • Leverage Shares 3x Long Moderna (MRNA) ETP Securities
    Weight: 2.05%
    19.6%
  • iShares VII PLC - iShares Core S&P 500 UCITS ETF
    Weight: 16.39%
    18.4%
  • iShares Physical Gold ETC
    Weight: 16.07%
    3.3%

Risk contribution shows how much each holding drives overall volatility, which can differ a lot from its weight. Here, the leveraged 3x Moderna position is only 2.05% of the portfolio but contributes 19.57% of total risk — a risk‑to‑weight ratio of 9.55. In contrast, the gold ETF is 16.07% of the portfolio yet only 3.33% of risk, acting as a stabiliser. The two big equity core funds each contribute slightly less risk than their weights, which is very reasonable. This tells a clear story: almost one‑fifth of total risk comes from a tiny leveraged satellite. That’s fine if consciously accepted, but it’s the main point to review if overall risk ever feels uncomfortably high.

Risk vs. return

This chart shows the Efficient Frontier, calculated using your current assets with different allocation combinations. It highlights the best balance between risk and return based on historical data. "Efficient" portfolios maximize returns for a given risk or minimize risk for a given return. Portfolios below the curve are less efficient. This is informational and not a recommendation to buy or sell any assets.

Click on the colored dots to explore allocations.

On the risk/return chart, the current portfolio sits below the efficient frontier, meaning that, for the same overall risk, a different mix of these existing holdings could deliver a higher expected return. The efficient frontier is the curve of “best possible” return for each risk level using only the current ingredients. Here, an alternative weighting at the same risk level boosts expected return to about 23.76%, and the optimal portfolio on the frontier shares that return at a volatility of 11.34%. In plain terms, no new products are needed; simply tweaking position sizes — especially dialling back the outsized risk from the leveraged note — could move the portfolio closer to a more efficient balance.

Dividends Info

  • iShares VII PLC - iShares Core S&P 500 UCITS ETF 0.90%
  • Weighted yield (per year) 0.15%

Dividend yield data is a bit patchy here, but we know the S&P 500 ETF yields around 0.9%, and the dedicated UK dividend ETF likely boosts the overall payout significantly. Dividends are the regular cash payments from companies, and they can matter a lot for investors seeking ongoing income or a smoother total return profile. The strong yield factor tilt suggests the portfolio is oriented toward above‑average dividends even if the headline yield number shown (0.15%) looks off, likely due to data quirks. In practice, the combination of UK dividend focus and global large‑cap exposure should provide a reasonable, though not ultra‑high, income stream alongside capital growth.

Ongoing product costs Info

  • iShares VII PLC - iShares Core S&P 500 UCITS ETF 0.10%
  • iShares UK Dividend UCITS 0.40%
  • Leverage Shares 3x Long Moderna (MRNA) ETP Securities 0.01%
  • iShares Physical Gold ETC 0.25%
  • Vanguard FTSE All-World UCITS ETF USD Accumulation 0.19%
  • Weighted costs total (per year) 0.25%

The portfolio’s total ongoing fee (TER) is around 0.25%, which is impressively low for an actively thought‑through, globally diversified ETF mix. Costs matter because they come off returns every year, a bit like friction slowing a moving car; lower friction lets more of the market’s growth reach you. Here, all major positions use low‑cost index or commodity products, which is exactly what supports better long‑term outcomes. The tiny 3x Moderna note cost is negligible in percentage terms given the small size. Overall, the cost structure is a clear strength and is very much in line with best practice for long‑term, diversified investing.

What next?

Create your own report?

Analyze your portfolio

Join our community!

Join Discord

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.

Help us improve Insightfolio

Your feedback makes a difference! Share your thoughts in our quick survey. Take the survey